Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,876 | -1,724 |
| Depreciation Amortization | 1,125 | 341 |
| Other Working Capital | 479 | 271 |
| Other Operating Activity | 720 | 864 |
| Operating Cash Flow | $-552 | $-248 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -39 | -37 |
| Purchase Of Investment | N/A | -4 |
| Other Investing Activity | 0 | -1 |
| Investing Cash Flow | $-39 | $-42 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 535 | 260 |
| Financing Cash Flow | $535 | $260 |
| Beginning Cash Position | 60 | 60 |
| End Cash Position | 4 | 30 |
| Net Cash Flow | $-56 | $-30 |
| Free Cash Flow | ||
| Operating Cash Flow | -552 | -248 |
| Capital Expenditure | -39 | -37 |
| Free Cash Flow | -591 | -285 |